In the last decade, we have been developing some gold (III) derivatives showing interesting
antitumor properties and reduced systemic and renal toxicity, compared to the clinically …

Complexes [Au (H2Ac4DH) Cl]∙ MeOH (1)[Au (H22Ac4Me) Cl] Cl (2)[Au (H22Ac4Ph) Cl] Cl∙
2H2O (3) and [Au (H22Bz4Ph) Cl] Cl (4) were obtained with 2-acetylpyridine …

Gold (I) phosphine complexes exhibit promising properties for anticancer drug development.
Here we report on a series of gold (I) phosphine complexes containing a naphthalimide …

A micro-electrochemical reaction cell was coupled to an electrospray mass spectrometer in
order to track redox transformations for two representative medicinal gold compounds-ie [(2 …

Breast cancers (BCs) may present dramatic diagnoses, both for ineffective therapies and for
the limited outcomes in terms of lifespan. For these types of tumors, the search for new drugs …

From wedding rings on fingers to stained glass windows, by way of Olympic medals, gold
has been highly prized for millennia. Nowadays, organometallic gold compounds occupy an …

The last decade has witnessed tremendous advances in the design of anticancer gold
complexes containing tertiary phosphines, a class of ligands that have significantly …

Gold compounds have emerged as a novel class of metallodrugs with a promising future in
medicinal inorganic chemistry. Despite gold compounds have been intensively investigated …

Bromido [3-ethyl-4-aryl-5-(2-methoxypyridin-5-yl)-1-propyl-1, 3-dihydro-2H-imidazol-2-
ylidene] gold (I) complexes (8a–h) with methoxy, methyl and fluorine substituents at different …

Organometallic gold complexes with N‐heterocyclic carbene (NHC) ligands have been
demonstrating promising properties as novel anticancer agents. Gold (I) NHC complexes …